| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/30/2011 | WO2011077342A1 Method |
| 06/30/2011 | WO2011077087A2 Method of establishing a fungal nail infection |
| 06/30/2011 | WO2011077080A1 Method of predicting capecitabine toxicity |
| 06/30/2011 | WO2011077004A1 Mutagenesis method |
| 06/30/2011 | WO2011076951A1 Plasmonic force manipulation in nanostructures |
| 06/30/2011 | WO2011076895A1 Hypoxia tumour markers |
| 06/30/2011 | WO2011076881A1 Mutant ldl receptor gene |
| 06/30/2011 | WO2011076814A1 Predictive value of il28b gene polymorphism combined with pretreatment serum ip-10 quantification for response to peginterferon and ribavirin is enhanced in comparison with any of these biomarkers alone |
| 06/30/2011 | WO2011076147A1 Plasma-based micro-rna biomarkers and methods for early detection of colorectal cancer |
| 06/30/2011 | WO2011076145A1 Tissue-based micro-rna methods for diagnosis of different subtypes of lung cancer |
| 06/30/2011 | WO2011076144A1 Compositions and methods for microrna expession profiling in plasma of lung cancer |
| 06/30/2011 | WO2011076143A1 Compositions and methods for microrna expression profiling of lung cancer |
| 06/30/2011 | WO2011076142A1 Compositions and methods for microrna expession profiling in plasma of colorectal cancer |
| 06/30/2011 | WO2011076141A1 Diagnostic kits comprising microrna biomarkers and methods for diagnosis of hepatocellular cancer |
| 06/30/2011 | WO2011076132A2 Sequence calibration method and sequence calibration device |
| 06/30/2011 | WO2011076130A1 Method and apparatus for compressing nucleotide sequence data |
| 06/30/2011 | WO2011076084A1 Novel gastric cancer biomarker and uses thereof |
| 06/30/2011 | WO2011075873A1 Pancreatic cancer markers, and detecting methods, kits, biochips thereof |
| 06/30/2011 | WO2011075774A1 Methods of enriching and detecting fetal nucleic acids |
| 06/30/2011 | WO2011031438A3 Porcine torque teno virus vaccines and diagnosis |
| 06/30/2011 | WO2011017145A3 Biomarkers for gossypol chemotherapy and methods of treating disease |
| 06/30/2011 | WO2011011738A3 Illumination in biotech instruments |
| 06/30/2011 | WO2011010870A3 Genetic marker for predicting the survival of a patient with early-stage lung cancer, and method for predicting survival using same |
| 06/30/2011 | WO2011003690A8 Highly sensitive rapid isothermal method for the detection of point mutations and snps, a set of primers and a kit therefor |
| 06/30/2011 | WO2011001135A3 Diagnosis and treatment of alzheimer's disease |
| 06/30/2011 | WO2010146214A3 Method for evaluating the athletic capabilities of a subject |
| 06/30/2011 | WO2010140824A9 Composition for diagnosis and determination of prognosis of hepatocellular carcinoma |
| 06/30/2011 | WO2010135310A8 Dna glycosylase/lyase and ap endonuclease substrates |
| 06/30/2011 | WO2010059914A8 Nucleic acid quantification products and processes |
| 06/30/2011 | WO2002006449A3 Method of detecting compounds that control fungal diseases via effects on sporulation |
| 06/30/2011 | US20110162116 Method For Growing Plants |
| 06/30/2011 | US20110162114 Selection method ii |
| 06/30/2011 | US20110162100 Sorghum fertility restorer genotypes and methods of marker-assisted selection |
| 06/30/2011 | US20110162098 Elite event ee-gm3 and methods and kits for identifying such event in biological samples |
| 06/30/2011 | US20110160594 Method for Testing Substances or Substance Mixtures and the Use Thereof |
| 06/30/2011 | US20110160293 Prmt1 for target genes of cancer therapy and diagnosis |
| 06/30/2011 | US20110160291 Oligonucleotide Compositions and Their Use to Induce Apoptosis |
| 06/30/2011 | US20110160290 Use of extracellular rna to measure disease |
| 06/30/2011 | US20110160289 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 06/30/2011 | US20110160288 Oip5 as a target gene for cancer therapy and diagnosis |
| 06/30/2011 | US20110160287 Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof |
| 06/30/2011 | US20110160280 Cancer-related genes, cdca5, epha7, stk31 and wdhd1 |
| 06/30/2011 | US20110160278 Methods For Selectively Modulating Survivin Apoptosis Pathways |
| 06/30/2011 | US20110160246 Neurodegenerative Protein Aggregation Inhibition Methods and Compounds |
| 06/30/2011 | US20110160231 Dihydroorotate dehydrogenase as antifungal drug target and quinazolinone-based inhibitors thereof |
| 06/30/2011 | US20110160216 Thymidylate Synthase Haplotype is Associated with Tumor Recurrence in Stage II and Stage III Colon Cancer Patients |
| 06/30/2011 | US20110160210 Control of intraocular pressure using alk5 modulation agents |
| 06/30/2011 | US20110160188 Paramyxovirus family inhibitors and methods of use thereof |
| 06/30/2011 | US20110160186 Methods of Treating CYP2D6 Alternative Metabolizers |
| 06/30/2011 | US20110160160 Methods for heat shock protein dependent cancer treatment |
| 06/30/2011 | US20110160132 Lymphangiogenesis-promoting agents |
| 06/30/2011 | US20110160125 Method and culture medium for enhanced detection of mycobacterium |
| 06/30/2011 | US20110160123 Targeting the efflux systems of mycobacterium tuberculosis |
| 06/30/2011 | US20110160119 Anti-inflammatory compounds and uses thereof |
| 06/30/2011 | US20110160091 Methods and Nucleic Acids for Analyses of Cell Proliferative Disorders |
| 06/30/2011 | US20110160086 Gene expression signature for classification of kidney tumors |
| 06/30/2011 | US20110160082 Mobility-Modified Nucleobase Polymers and Methods of Using Same |
| 06/30/2011 | US20110160081 functional complementation assay for defined gpcr oligomers |
| 06/30/2011 | US20110160080 Diagnosis of Melanoma and Solar Lentigo by Nucleic Acid Analysis |
| 06/30/2011 | US20110160075 Diagnostic assay for orientia tsutsugamushi by detection of responsive gene expression |
| 06/30/2011 | US20110159601 Study of polymer molecules and conformations with a nanopore |
| 06/30/2011 | US20110159536 Device for capturing object and method for using the same |
| 06/30/2011 | US20110159535 Preparation and use of nucleated red blood cell simulating particles and hematology control mixtures |
| 06/30/2011 | US20110159534 Method and culture medium for enhanced detection of mycobacterium |
| 06/30/2011 | US20110159533 Bioparticle capture device, and use thereof |
| 06/30/2011 | US20110159532 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 06/30/2011 | US20110159531 Method and apparatus for measuring amount of substance |
| 06/30/2011 | US20110159530 Methods of quantifying biomarkers |
| 06/30/2011 | US20110159529 Fusion protein having luminescence activity |
| 06/30/2011 | US20110159527 Methods and kits for diagnosing neurodegenerative disease |
| 06/30/2011 | US20110159524 Method for monitoring hydrolytic activity |
| 06/30/2011 | US20110159522 Three-Dimensional Microfluidic Platforms and Methods of Use Thereof |
| 06/30/2011 | US20110159513 Methods and systems for predicting response of cells to a therapeutic agent |
| 06/30/2011 | US20110159512 Polynucleotide sequences of candida dubliniensis and probes for detection |
| 06/30/2011 | US20110159511 Microfluidic Device Screening Method |
| 06/30/2011 | US20110159510 Use of methylated or unmethylated line-1 dna as a cancer marker |
| 06/30/2011 | US20110159509 Use of runx3 and mir-532-5p as cancer markers and therapeutic targets |
| 06/30/2011 | US20110159508 GFATS as Modifiers of the P53 Pathway and Methods of Use |
| 06/30/2011 | US20110159507 Method for detecting the drug effects of dna methylation-inhibitors |
| 06/30/2011 | US20110159506 Methods for assessing rna patterns |
| 06/30/2011 | US20110159505 Method of Manufacturing a Mixture of Amplified Double-Stranded Nucleic Acids Comprising Unknown Sequence |
| 06/30/2011 | US20110159504 Methylation markers for sensitivity to microtube based therapies and methods of use |
| 06/30/2011 | US20110159503 Dna extraction method for bursaphelenchus xylophilus from wood chips, lamp primer set for bursaphelenchus xylophilus, and detection method for bursaphelenchus xylophilus from wood chips |
| 06/30/2011 | US20110159502 Use of methylated or unmethylated line-1 dna as a cancer marker |
| 06/30/2011 | US20110159501 Use of methylated or unmethylated line-1 dna as a cancer marker |
| 06/30/2011 | US20110159500 Compositions including ginger for the amelioration or prevention of inflammatory conditions |
| 06/30/2011 | US20110159499 Methods and compositions for detecting genetic material |
| 06/30/2011 | US20110159498 Methods, agents and kits for the detection of cancer |
| 06/30/2011 | US20110159497 Freeze-dried compositions for carrying out pcr and other biochemical reactions |
| 06/30/2011 | US20110159496 Molecular diagnosis and classification of malignant melanoma |
| 06/30/2011 | US20110159495 Method for the quantitative detection of an organic substance in a sample |
| 06/30/2011 | US20110159494 Analyzing the FMR1 Gene |
| 06/30/2011 | US20110159493 Diagnostic polymorphisms for cardiac disease |
| 06/30/2011 | US20110159492 Diffuse Large B-Cell Lymphoma Markers and Uses Therefore |
| 06/30/2011 | US20110159491 Method for detecting cytosine methylation in DNA samples |
| 06/30/2011 | US20110159490 Use of the combing process for the identification of dna origins of replication |
| 06/30/2011 | US20110159489 Single nucleotide polymorphisms associated with dietary weight loss |
| 06/30/2011 | US20110159488 Primers for Amplification and Sequencing of Eubacterial 16S rDNA for Identification |
| 06/30/2011 | US20110159487 Identification of a Gene Expression Profile that Differentiates Ischemic and Nonischemic Cardiomyopathy |
| 06/30/2011 | US20110159486 Cell cycle switch 52(ccs52) and methods for increasing yield |